Massive new registry aims to unlock secrets of deadly heart condition
NCT ID NCT07643610
First seen Jun 22, 2026 · Last updated Jun 22, 2026
Summary
This registry will collect health data from 8,000 adults with cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood. Researchers aim to track what treatments are used and how patients fare, including survival rates in the hospital and up to 90 days later. The goal is to better understand this condition and potentially improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION (MI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Basel
RECRUITINGBasel, Canton of Basel-City, 4031, Switzerland
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could reveal patterns that lead to better treatments and survival rates for people with cardiogenic shock.
What could go wrong
This is an observational registry, not a treatment trial. It collects data but does not test any new therapy, so direct patient benefits are not guaranteed.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.